skip to Global Navigation Bar skip to main content


homeHome > About Us > Recruitment > News

News

News Content
Daewoong Pharmaceutical announced the excellence of Nabota through an overseas specialist training program.
Date 2019-04-15 Hit 2161
list
News List
Prev The clinical findings of Botulinum Toxin manufactured by Daewoong have been published on international journal regarding the comparison with Botox
Next A global symposium pays attention to Nav 1.7 Chronic Pain Treatment, DWP17061.